SOURCE: Conversant Bio

Conversant Bio

December 17, 2013 03:00 ET

Conversant Bio Releases Immunology E-Book

New Guide Provides Extensive Information for Researchers Working on Autoimmune Disorders

HUNTSVILLE, AL--(Marketwired - Dec 17, 2013) - Conversant Bio, a global leader in supplying the highest-quality human tissue and viable cell samples, today announced it is publishing a new e-book to provide researchers with a guide to autoimmune disorders. The e-book Researchers Guide to Immunology: From the Real World to the Lab, is available as a free download at http://www.conversantbio.com/researchers-guide-to-immunology-ebook.

Autoimmune disorders are characterized by an immune system attacking its body's own healthy tissues. More than 80 autoimmune diseases have been recognized, affecting approximately 50 million Americans. Conversant Bio's e-book sets a new standard in resources for researching these life-altering disorders. The guide provides researchers with an extensive understanding of autoimmune disorders and offers in-depth information on patient lifestyle.

The e-book also focuses on major research challenges facing scientists working on autoimmune disorders:

  • Rheumatoid Arthritis
  • Systemic Lupus Erythematosus
  • Ulcerative Colitis
  • Crohn's Disease

"Research occurs every day. Our e-book includes an extensive amount of information on autoimmune disorders, written by a company with an experienced research staff," says Luke Doiron, Chief Commercial Officer for Conversant Bio. "We are a leader in supplying the highest-quality human tissue samples. Our goal is to make obtaining these samples easy and painless so that the customer can focus on the research."

To download Researchers Guide to Immunology: From the Real World to the Lab, visit http://www.conversantbio.com/researchers-guide-to-immunology-ebook.

About Conversant Bio
Conversant Bio provides researchers around the world with hyper-annotated tissue samples in order to conduct informed, cutting-edge investigations into many of today's most problematic diseases. With a large prospective collections network of 36 U.S.-based clinical sites and an IRB-reviewed chain of custody quality control system, Conversant Bio provides the highest-quality samples on time and on budget. For additional information about Conversant Bio's services, visit the company's website at http://www.conversantbio.com.